Iradimed (IRMD) Free Cash Flow (2013 - 2026)

Iradimed (IRMD) has 14 years of Free Cash Flow data on file, last reported at $7.9 million in Q1 2026.

• Free Cash Flow for Q1 2026 came in at $7.9 million, up 1225.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.6 million (up 116.3% YoY), and the FY2025 annual result was $24.3 million, up 37.87% from the prior year.
• Free Cash Flow declined to $7.9 million in Q1 2026 per IRMD's latest filing, from $12.7 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $12.7 million in Q4 2025 and troughed at -$1.7 million in Q1 2023.
• A 5-year average of $4.2 million and a median of $3.6 million in 2024 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2023 and 2026: Free Cash Flow plunged 240.79% in 2023, then soared 1225.55% in 2026.
• A 5-year view of Free Cash Flow shows it stood at $2.8 million in 2022, then surged by 34.91% to $3.8 million in 2023, then declined by 16.14% to $3.2 million in 2024, then surged by 298.48% to $12.7 million in 2025, then plunged by 38.08% to $7.9 million in 2026.
• Business Quant data shows IRMD's Free Cash Flow at $7.9 million in Q1 2026, $12.7 million in Q4 2025, and $5.8 million in Q3 2025.